OmniAb (OABI) Amortization - Intangibles (2022 - 2026)
OmniAb (OABI) reported Amortization - Intangibles of $6.0 million for Q1 2026, up 85.87% year-over-year from $3.2 million in Q1 2025, and up 86.8% on a QoQ basis from $3.2 million in Q4 2025.
OmniAb (OABI) has 5 years of Amortization - Intangibles data on file, last reported at $6.0 million in Q1 2026.
- Quarterly Amortization - Intangibles rose 85.87% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.6 million (down 9.61% YoY) and the FY2025 annual result came in at $12.9 million, down 25.82% from the prior year.
- Amortization - Intangibles climbed to $6.0 million in Q1 2026 per OABI's latest filing, from $3.2 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $6.1 million in Q4 2024 and bottomed at $3.1 million in Q2 2022.
- The 5-year median for Amortization - Intangibles is $3.4 million (2024), against an average of $3.7 million.
- The widest annual swing landed in 2025, when Amortization - Intangibles tumbled 47.4%; it then soared 85.87% in 2026.
- Tracing OABI's Amortization - Intangibles over 5 years: stood at $3.2 million in 2022, then gained by 6.47% to $3.4 million in 2023, then soared by 79.25% to $6.1 million in 2024, then plunged by 47.4% to $3.2 million in 2025, then jumped by 86.8% to $6.0 million in 2026.
- Per Business Quant, the three latest OABI Amortization - Intangibles figures stand at $6.0 million (Q1 2026), $3.2 million (Q4 2025), and $3.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | 6.11 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 3.41 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 3.20 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 3.40 Mn |